Aldeyra Therapeutics, Inc. (FRA:137)
4.492
-0.075 (-1.64%)
At close: Jan 28, 2026
Aldeyra Therapeutics Employees
Aldeyra Therapeutics had 8 employees as of September 30, 2025. The number of employees decreased by 1 or -11.11% compared to the same quarter last year.
Employees
8
Change
-1
Growth
-11.11%
Revenue / Employee
n/a
Profits / Employee
€4,601,772
Market Cap
271.43M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 8 | -1 | -11.11% |
| Jun 30, 2025 | 8 | -2 | -20.00% |
| Mar 31, 2025 | 8 | -2 | -20.00% |
| Dec 31, 2024 | 9 | -1 | -10.00% |
| Sep 30, 2024 | 9 | -3 | -25.00% |
| Jun 30, 2024 | 10 | -5 | -33.33% |
| Mar 31, 2024 | 10 | -5 | -33.33% |
| Dec 31, 2023 | 10 | -5 | -33.33% |
| Sep 30, 2023 | 12 | -3 | -20.00% |
| Jun 30, 2023 | 15 | 1 | 7.14% |
| Mar 31, 2023 | 15 | 1 | 7.14% |
| Dec 31, 2022 | 15 | 3 | 25.00% |
| Sep 30, 2022 | 15 | 4 | 36.36% |
| Jun 30, 2022 | 14 | 4 | 40.00% |
| Mar 31, 2022 | 14 | 6 | 75.00% |
| Dec 31, 2021 | 12 | 1 | 9.09% |
| Sep 30, 2021 | 11 | 0 | - |
| Jun 30, 2021 | 10 | 0 | - |
| Mar 31, 2021 | 8 | -7 | -46.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Eleving Group | 3,671 |
| ÜSTRA Hannoversche Verkehrsbetriebe Aktiengesellschaft | 2,500 |
| SIMONA Aktiengesellschaft | 1,864 |
| Novabase S.G.P.S. | 1,281 |
| centrotherm international AG | 755 |
| Allane SE | 703 |
| EUWAX Aktiengesellschaft | 84 |
| Sino AG | 24 |
Aldeyra Therapeutics News
- 15 days ago - Aldeyra Therapeutics (ALDX) Leads in Earnings Momentum - GuruFocus
- 4 weeks ago - Aldeyra Therapeutics: Reproxalap's March 2026 FDA Decision Is The Defining Catalyst - Seeking Alpha
- 6 weeks ago - Aldeyra Therapeutics Inc Regulatory Update Conference Call Transcript - GuruFocus
- 6 weeks ago - Aldeyra Therapeutics, Inc. (ALDX) Discusses PDUFA Target Action Date Extension for Reproxalap in Dry Eye Disease Transcript - Seeking Alpha
- 6 weeks ago - Aldeyra Therapeutics (ALDX) Faces FDA Review Delay for Reproxalap - GuruFocus
- 6 weeks ago - Aldeyra drops as FDA delays review of marketing application for lead drug - Seeking Alpha
- 6 weeks ago - FDA Extends Review Timeline For Aldeyra's Reproxalap NDA In Dry Eye Disease - Nasdaq
- 6 weeks ago - Aldeyra (ALDX) Receives Extended FDA Action Date for Reproxalap NDA - GuruFocus